The Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental ...
Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. The drug's journey from the lab through regulatory approval ...
(NEW YORK) — From a pig kidney transplant to restoring genetic deafness, 2024 was a year full of medical breakthroughs. The breakthroughs include the discovery of a cause of an autoimmune disease, the ...
(Reuters) -The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades. The labeling ...
NEW YORK (Reuters Health) - Studies of schizophrenia drugs are increasingly finding lesser effects because more patients are responding to drug-free placebos used for comparison, according to a new ...
In the months after 24-year-old D.J. was diagnosed with schizophrenia, he searched online for answers to questions that felt urgent and existential. Does it get really bad over time? Will I be able to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback